ProQR Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.

CEO

Daniel Anton de Boer

CEODaniel Anton de Boer

Employees

157

Employees157

Headquarters

Leiden, Zuid-Holland

HeadquartersLeiden, Zuid-Holland

Founded

2012

Founded2012

Employees

157

Employees157

PRQR Key Statistics

Market cap

157.59M

Market cap157.59M

Price-Earnings ratio

-5.13

Price-Earnings ratio-5.13

Dividend yield

—

Dividend yield—

Average volume

167.91K

Average volume167.91K

High today

$1.99

High today$1.99

Low today

$1.93

Low today$1.93

Open price

$1.95

Open price$1.95

Volume

50.79K

Volume50.79K

52 Week high

$3.29

52 Week high$3.29

52 Week low

$1.11

52 Week low$1.11

PRQR News

TipRanks 5d

ProQR Therapeutics Announces Board Nomination and AGM - TipRanks.com - TipRanks

ProQR Therapeutics BV (PRQR) has released an update. ProQR Therapeutics has announced their upcoming Annual General Meeting for shareholders on May 22, 2024, a...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell